A study of atypical APTT derivative curves on the ACL TOP coagulation analyser-Reference-Cited by-同舟云学术

A study of atypical APTT derivative curves on the ACL TOP coagulation analyser

Published:2010-07-23 Issue:1 Volume:33 Page:67-78
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:

Author:

SOLANO C.,ZERAFA P.,BIRD R.

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Reference8 articles.

1. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies of the Scientific and Standardisation Committee of the ISTH;Brandt;Thrombosis and Haemostasis,1995

2. Activated partial thromboplastin time waveform analysis: a new tool to detect infection?;Chopin;Critical Care Medicine,2006

3. Prognostic implications of a biphasic waveform for APTT analysis in a district general hospital;Mair;International Journal of Laboratory Hematology,2008

4. Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation;Matsumoto;Clinical and Applied Thrombosis/Hemostasis,2006a

5. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay;Matsumoto;Journal of Thrombosis and Haemostasis,2006b

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clot waveform analysis in acute promyelocytic leukemia;Blood Coagulation & Fibrinolysis;2023-11-08

2. Performance and Interpretation of Clot Waveform Analysis;Methods in Molecular Biology;2023

3. Progression of clot waveform analysis;Japanese Journal of Thrombosis and Hemostasis;2023

4. The activated partial thromboplastin time‐clot waveform analysis in hemophilia: Does it help in differentiation?;International Journal of Laboratory Hematology;2022-12-10

5. Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab;Clinical and Experimental Medicine;2022-05-25